Analysis of Off-label Use of Intravenous Immunoglobulin in a Tertiary Health Care Facility: A Record-based Cross-sectional Study
Introduction: The off-label clinical use of Intravenous Immunoglobulin (IVIG) has increased despite the existence of its approved indications by drug regulatory agencies. IVIG is an expensive drug and its availability is also limited; hence, judicious use of IVIG is highly recommended. Aim: To eval...
Saved in:
| Main Authors: | Mitali Ganapati, Snigdha Rani Panigrahy, Abinash Panda, Jayanti Prava Behera |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
JCDR Research and Publications Private Limited
2025-07-01
|
| Series: | Journal of Clinical and Diagnostic Research |
| Subjects: | |
| Online Access: | https://jcdr.net/article_fulltext.asp?issn=0973-709x&year=2025&month=August&volume=19&issue=8&page=FC01-FC05&id=21280 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Prescribing of meprobamate-containing combination analgesics in South Africa
by: I. Truter
Published: (2016-12-01) -
Systemic isotretinoin in the management of acne – a patient questionnaire survey
by: Solé Burger, et al.
Published: (2009-10-01) -
Off-Label Drug Use in Oncology
by: E. V. Karabina, et al.
Published: (2022-07-01) -
RETRACTED: International experience in drug names assessment: European Medicines Agency
by: A. N. Mironov, et al.
Published: (2018-12-01) -
A review to determine regulatorily and reimbursement successes of studies conducted using data from Canadian patient support programs based on the real-world evidence guidelines published by Canadian drug agency and health Canada
by: Catherine Y. Lau
Published: (2025-08-01)